Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| VIASAT INC | VSAT | 19.35% |
| OLD SECOND B | OSBC | 5.76% |
| GAMCO INVEST | GBL | 4.61% |
| CORNING | GLW | 4.47% |
| SYNCHRONOSS | SNCR | 4.23% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Quality Systems ( QSII - Analyst Report ) reported fourth-quarter fiscal 2012 (ended March 31) adjusted (excluding one-time items other than stock-based compensation expense) earnings per share of 26 cents missing the Zacks Consensus Estimate of 27 cents. The company stated earnings per share of $1.30 for fiscal 2012 missing the Zacks Consensus Estimate of $1.31.
Net income dropped 18.8% year over year to $150.7 million (25 cents per share) in the reported quarter partly due to higher expenditures.
Revenues
Sales stood at $109 million in the fourth quarter, up 12.2% year over year, missing the Zacks Consensus Estimate of $111 million. Revenues were $429.8 million in fiscal 2012, up 21.6%, also missing the Zacks Consensus Estimate of $431 million.
Segment-wise Results
System sales amounted to $34.8 million, down 5% year over year. Revenues from the two subcomponents were $26.6 million (down 16.2% year over year) from Software, Hardware and Supplies and $8.3 million (higher 67.2%) from Implementation and Training Services.
Maintenance, EDI, Revenue Cycle Management and other Services revenues amounted to $74.2 million, up 22.7% year over year. Segment sales were reported under four separate headings. Maintenance charges were $35.9 million, up 23.5%. Electronic data interchange services sales were $13.1 million, up 21.6%. Revenue Cycle Management sales of $11.4 million were down 1.9% and the “Other” sub-segment amounted to $13.8 million, up 52.9%.
Margin
Gross margin stood at 61.5% in the fourth quarter, lower than 65.8% achieved in the prior-year quarter. Operating margin came to 21.4%, also lower than 29.3% in the year-ago quarter.
Balance Sheet
Cash, cash equivalents and marketable securities were $134.3 million at the end of the fourth quarter, up 15.3% year over year.
Our Take
Quality Systems runs a pure-play business model, in an attractive industry, with a large number of catalysts, which provoke frequent speculation about mergers and acquisition. In recent times, the company has not only well managed its ambulatory clinical deals but, in addition, has nicely executed several enterprise contracts. Also, on the positive side, we derive comfort from the high proportion of recurring revenues and steady growth in its NextGen pipeline.
However, competition is intense from well regarded players such as Athenahealth ( ATHN - Analyst Report ) , Allscripts Healthcare Solutions ( MDRX - Analyst Report ) , Cerner Corporation ( CERN - Analyst Report ) and others. Price discounting is frequent, particularly on the lower end, and Software as a Service (SaaS) based model appears to have exacerbated pricing pressure.
Quality Systems has traditionally focused on providing solutions for physician practices. However, core ambulatory EHR providers, such as Quality Systems, will see opportunities shrinking for selling their products as physician groups are increasingly getting absorbed into hospitals.
Read the full reports :
Analyst Report on CERN
Analyst Report on ATHN
Analyst Report on MDRX
Analyst Report on QSII